Mandate

Vinge advises Abacus Bidco Oy (which is the parent company of Accountor Software recently acquired by KKR) in the acquisition of certain subsidiaries and assets of 24SevenOffice Group AB (“24SevenOffice”)  

24SevenOffice is a listed company (First North Stockholm) that provides modular software for accounting, ERP and business services that automate processes using AI.

The transaction primarily relates to ERP-related subsidiaries and assets, including 24SevenOffice Norway AS, 24SevenOffice Scandinavian Systems and 24SevenOffice Sweden AB. Following completion of the transaction, the acquired assets and subsidiaries will be integrated with Accountor Software.

The purchase price for the ERP-related subsidiaries and assets corresponds to an enterprise value of approximately SEK 2.4 billion.

The transaction is subject to approval by the shareholders of 24SevenOffice and regulatory approval.

Vinge's team consisted primarily of Christina Kokko, Matthias Pannier, Gustav Persson and Ian Linde (M&A), Sofie Bjärtun and Joel Magnusson (Capital Markets and Public M&A), Johan Gavelin (IP), Alice Göransson (Employment), Madelene Andersson (Real Estate), Daniel Wendelsson (FDI), Christoffer Nordin and Katja Häglund (Commercial Agreements), Nicklas Thorgerzon (IT and GDPR), Calle Tengwall Pagels and William Carlberg Johansson (Banking and Finance), Caroline Krassén (Financial Services), Caroline Löv and Filippa Bergkvist (Transaction Support).

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026